Tower Research Capital LLC (Trc) Immunity Bio, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.29 Billion
Q1 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,010 shares of IBRX stock, worth $17,429. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,010

Previous 50,799 88.17%

Holding current value

$17,429

Previous $130,000 86.15%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.32 - $3.9 $103,910 - $174,677	-44,789 Reduced 88.17%	6,010 $18,000
Q4 2024 Feb 13, 2025	BUY	$2.56 - $6.17 $118,330 - $285,195	46,223 Added 1010.12%	50,799 $130,000
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $56,606 - $114,235	-17,050 Reduced 78.84%	4,576 $16,000
Q2 2024 Aug 13, 2024	BUY	$4.82 - $9.15 $18,441 - $35,007	3,826 Added 21.49%	21,626 $136,000
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $27,154 - $51,871	8,407 Added 89.5%	17,800 $95,000
Q4 2023 Feb 13, 2024	BUY	$1.25 - $5.21 $3,555 - $14,817	2,844 Added 43.43%	9,393 $47,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $3.1 $9,442 - $22,692	-7,320 Reduced 52.78%	6,549 $11,000
Q2 2023 Aug 14, 2023	SELL	$1.53 - $6.41 $20,154 - $84,438	-13,173 Reduced 48.71%	13,869 $38,000
Q1 2023 May 09, 2023	BUY	$1.35 - $4.78 $27,953 - $98,974	20,706 Added 326.8%	27,042 $49,000
Q4 2022 Feb 10, 2023	SELL	$4.35 - $6.77 $487 - $758	-112 Reduced 1.74%	6,336 $33,000
Q3 2022 Nov 10, 2022	BUY	$3.65 - $6.43 $2,445 - $4,308	670 Added 11.6%	6,448 $32,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $88,646 - $203,092	-33,077 Reduced 85.13%	5,778 $22,000
Q1 2022 May 12, 2022	BUY	$5.05 - $7.53 $63,998 - $95,427	12,673 Added 48.4%	38,855 $218,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $80,865 - $145,187	14,262 Added 119.65%	26,182 $159,000
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $42,649 - $66,230	4,651 Added 63.98%	11,920 $116,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $75,498 - $126,111	5,630 Added 343.5%	7,269 $104,000
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $21,028 - $69,247	1,639 New	1,639 $39,000

Others Institutions Holding IBRX

# of Institutions

239

Shares Held

79.9M

Call Options Held

1.08M

Put Options Held

2.73M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.16B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Immunity Bio, Inc. Transaction History